Dr. Abud Bakri

Yes, yes, yes.

So we're working on aggregating all this data together into a NE1.study to put it all together.

Because all the anecdata exist, but put it together somewhere.

At least we can see what the signals are.

For example, on Reddit, you'll find signals of hematomas getting worse.

Which makes sense with the VEGF pathway.

I've heard this.

It makes sense, though, if it's promoting angiogenesis.

Based on the mechanism, it does make sense.

Now, BPC-157 is not a uniform angiogenesis upregulator.

In some models, it decreases VEGF.

In a melanoma model, a cell line.

So it might be potentially anti-cancer, but we need to test it.

We don't know.

And what's really unfortunate about this compound, it's very promising.

It has all this cool literature in animals, and we just don't know when it comes to humans.

Just the one enema.

Yeah, exactly.

Yeah, exactly.

And we'd love to know, because, like, if it does work, like, I could see a million use cases in the ICU that we could use, you know, BPC-157 to really help people out, especially during the critical illness, because, like, in the ICU, people get gastric ulcers.